How can I differentiate branch retinal vein occlusion (BRVO) from branch retinal artery occlusion (BRAO)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Differentiating BRVO from BRAO

BRVO presents with dilated, tortuous veins, flame-shaped hemorrhages, and retinal edema in a wedge-shaped distribution, while BRAO presents with retinal whitening/opacification in a wedge-shaped distribution with narrowed arteries and minimal hemorrhage.

Key Clinical Distinguishing Features

Branch Retinal Vein Occlusion (BRVO)

  • Venous findings: Dilated, engorged, tortuous retinal veins in the affected quadrant 1
  • Hemorrhage pattern: Extensive flame-shaped and dot-blot intraretinal hemorrhages along the distribution of the occluded vein 1
  • Retinal appearance: Retinal edema and thickening, cotton-wool spots
  • Location: Typically occurs at arteriovenous crossing points where vessels share a common adventitial sheath, most commonly in the superotemporal quadrant 1
  • Onset: Vision loss may be gradual or sudden but typically less acute than BRAO

Branch Retinal Artery Occlusion (BRAO)

  • Arterial findings: Narrowed arteries with "cattle tracking" or "boxcar segmentation" of blood flow in the affected vessel 2, 3
  • Retinal appearance: Retinal whitening/opacification in a wedge-shaped distribution corresponding to the territory of the occluded artery 2
  • Hemorrhage pattern: Minimal to no hemorrhages (this is critical—hemorrhages are NOT a primary feature of arterial occlusions) 2
  • Onset: Sudden, painless vision loss occurring over seconds 2
  • Visual acuity: Often better preserved if macula is spared; final VA of 20/40 or better in 89% of permanent BRAO 4

Diagnostic Algorithm

Step 1: Assess the Vascular Pattern

  • Dilated veins + extensive hemorrhages → Think BRVO
  • Narrowed arteries + retinal whitening → Think BRAO

Step 2: Evaluate Hemorrhage Distribution

  • Extensive flame-shaped hemorrhages radiating from the occlusion site → BRVO 1
  • Minimal or no hemorrhages with retinal whitening → BRAO 2

Step 3: OCT Findings

  • BRVO: Retinal thickening, cystoid macular edema, intraretinal fluid 1
  • BRAO: Hyperreflectivity of inner retinal layers (particularly inner nuclear layer), retinal thinning in chronic cases 2, 3

Step 4: Fluorescein Angiography

  • BRVO: Delayed venous filling, venous tortuosity, areas of capillary non-perfusion, late leakage from damaged vessels 1
  • BRAO: Delayed arterial filling in affected segment, complete capillary dropout with sharp demarcation between perfused and non-perfused retina, NO late leakage 2, 3

Critical Pitfalls to Avoid

Combined occlusions can occur: Rarely, patients may present with both BRAO and BRVO simultaneously in the same eye 3, 5. In these cases, you'll see features of both conditions—narrowed arteries with cattle tracking AND dilated veins with hemorrhages in the same quadrant. This combination is associated with multiple systemic comorbidities including diabetes, hypertension, dyslipidemia, and hyperhomocysteinemia 3.

Early BRAO may be subtle: In the first few hours after BRAO, retinal whitening may not yet be fully developed, making diagnosis challenging 2. Look for subtle inner retinal hyperreflectivity on OCT and delayed arterial perfusion on FA.

Timing matters: BRVO hemorrhages may obscure underlying retinal details initially, while BRAO retinal whitening fades over days to weeks as retinal atrophy develops 2, 4.

Systemic Workup Implications

Both conditions require systemic evaluation but with different urgency:

  • BRAO: Requires immediate referral to stroke center for acute intervention consideration, as it represents an embolic event with high stroke risk 2
  • BRVO: Requires timely but less urgent cardiovascular risk factor assessment and optimization of hypertension, diabetes, and lipid control 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.